Keith Crandell is of Twist Bioscience Corp. Currently has a direct ownership of 18,004 shares of TWST, which is worth approximately $748,606. The most recent transaction as insider was on Feb 06, 2024, when has been sold 5,815 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18K
0% 3M change
47.71% 12M change
Total Value Held $748,606

KEITH CRANDELL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2024
BUY
Grant, award, or other acquisition
-
5,815 Added 24.41%
18,004 Common Stock
Feb 07 2023
BUY
Grant, award, or other acquisition
-
8,212 Added 40.25%
12,189 Common Stock
Feb 08 2022
BUY
Grant, award, or other acquisition
-
3,491 Added 46.75%
3,977 Common Stock
Aug 12 2021
SELL
Open market or private sale
$150,985 $106.93 p/Share
1,412 Reduced 74.39%
486 Common Stock
Feb 03 2021
BUY
Grant, award, or other acquisition
-
486 Added 20.39%
1,898 Common Stock

Also insider at

QTRX
Quanterix Corp Healthcare
MASS
908 Devices Inc. Healthcare
DALS
DA32 Life Science Tech Acquisition Corp. Financial Services
SANA
Sana Biotechnology, Inc. Healthcare
BOLD
Boundless Bio, Inc.
KC

Keith Crandell

Chicago, IL

Track Institutional and Insider Activities on TWST

Follow Twist Bioscience Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TWST shares.

Notify only if

Insider Trading

Get notified when an Twist Bioscience Corp insider buys or sells TWST shares.

Notify only if

News

Receive news related to Twist Bioscience Corp

Track Activities on TWST